Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: inhalation
Type of information:
other: Bibliographic source
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data

Data source

Reference
Reference Type:
review article or handbook
Title:
Metal Toxicity in Mammals, 1.
Author:
Luckey, T.D. and B. Venugopal.
Year:
1977
Bibliographic source:
New York: Plenum Press

Materials and methods

GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Antimony
EC Number:
231-146-5
EC Name:
Antimony
Cas Number:
7440-36-0
Molecular formula:
Sb

Results and discussion

Results of examinations

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
Symptoms of chronic antiimony intoxication are dyspnea, weight and hair loss, papular eruptions on the skin, jaundice, albuminuria, damage to the heart and liver, hyperplasia of the spleen, glomerular nephritis, abnormal increase in erythrocytes, and decrease in leukocytes.

Applicant's summary and conclusion

Conclusions:
Chronic inhalation of subtoxic doses of antimony salts causes interstitial pneumonitis, intraalveolar lipoid deposits, and liver and cardiac damage.